{"id":"https://openalex.org/W2013510617","doi":"https://doi.org/10.1182/blood-2008-02-137943","title":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan\u2013Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia","display_name":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan\u2013Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia","publication_year":2008,"publication_date":"2008-10-17","ids":{"openalex":"https://openalex.org/W2013510617","doi":"https://doi.org/10.1182/blood-2008-02-137943","mag":"2013510617","pmid":"https://pubmed.ncbi.nlm.nih.gov/18931344","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4968372"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2008-02-137943","doi":"https://doi.org/10.1182/blood-2008-02-137943","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2008-02-137943","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4968372","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102743501","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0003-3386-6540","observed_orcids":["https://orcid.org/0000-0003-3386-6540"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan M. O'Brien","raw_affiliation_strings":["M. D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004302802","display_name":"David F. Claxton","orcid":"https://orcid.org/0000-0001-9209-2405","observed_orcids":["https://orcid.org/0000-0001-9209-2405"]},"institutions":[{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. Claxton","raw_affiliation_strings":["Milton S. Hershey Medical Center, Hershey, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Milton S. Hershey Medical Center, Hershey, PA;","institution_ids":["https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061856914","display_name":"Michael Crump","orcid":"https://orcid.org/0000-0002-2230-8538","observed_orcids":["https://orcid.org/0000-0002-2230-8538"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michael Crump","raw_affiliation_strings":["Princess Margaret Hospital, Toronto, ON;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Hospital, Toronto, ON;","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046097970","display_name":"Stefan H Faderl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan Faderl","raw_affiliation_strings":["M. D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Kipps","raw_affiliation_strings":["University of California San Diego;","University of California at San Diego"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego;","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"University of California at San Diego","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027575595","display_name":"Michael J. Keating","orcid":"https://orcid.org/0000-0002-9121-6450","observed_orcids":["https://orcid.org/0000-0002-9121-6450","https://orcid.org/0000-0002-4008-9893"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Keating","raw_affiliation_strings":["M. D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076058689","display_name":"Jean Viallet","orcid":"https://orcid.org/0000-0003-1137-0093","observed_orcids":["https://orcid.org/0000-0003-1137-0093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean Viallet","raw_affiliation_strings":["Gemin X, Malvern, PA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gemin X, Malvern, PA; and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082606841","display_name":"Bruce D. Cheson","orcid":"https://orcid.org/0000-0001-9255-7655","observed_orcids":["https://orcid.org/0000-0001-9255-7655","https://orcid.org/0000-0002-6246-4308"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce D. Cheson","raw_affiliation_strings":["Georgetown University, Washington, DC","GEORGETOWN UNIVERSITY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University, Washington, DC","institution_ids":["https://openalex.org/I184565670"]},{"raw_affiliation_string":"GEORGETOWN UNIVERSITY","institution_ids":["https://openalex.org/I184565670"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":12.7515,"has_fulltext":false,"cited_by_count":271,"citation_normalized_percentile":{"value":0.99116434,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"113","issue":"2","first_page":"299","last_page":"305"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gx15-070","display_name":"GX15-070","score":0.9769999980926514},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8730000257492065},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8059999942779541},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7160000205039978},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6109370589256287},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.524958610534668},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5205520391464233},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5079270005226135},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.46923238039016724},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4411359429359436},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4130246341228485},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3378818929195404},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12426301836967468}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013922","descriptor_name":"Thrombocytosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013922","descriptor_name":"Thrombocytosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050998","descriptor_name":"bcl-2 Homologous Antagonist-Killer Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051028","descriptor_name":"bcl-2-Associated X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1182/blood-2008-02-137943","doi":"https://doi.org/10.1182/blood-2008-02-137943","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2008-02-137943","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4968372","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4968372","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},{"id":"pmid:18931344","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18931344","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.918.5126","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.918.5126","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodjournal.org/content/bloodjournal/113/2/299.full.pdf?sso-checked%3Dtrue","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4968372","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4968372","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306439","display_name":"Multiple Myeloma Research Foundation","ror":"https://ror.org/03ww1bx13"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308594","display_name":"CLL Global Research Foundation","ror":"https://ror.org/0472hmc50"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W60865865","https://openalex.org/W180295822","https://openalex.org/W1983477246","https://openalex.org/W1986688227","https://openalex.org/W1995560549","https://openalex.org/W2002816684","https://openalex.org/W2069105832","https://openalex.org/W2085419794","https://openalex.org/W2092502635","https://openalex.org/W2113068679","https://openalex.org/W2121244744","https://openalex.org/W2135080095","https://openalex.org/W2146907762","https://openalex.org/W2465735492","https://openalex.org/W2965274063","https://openalex.org/W6766083666"],"related_works":["https://openalex.org/W7096148443","https://openalex.org/W2589069501","https://openalex.org/W2465735492","https://openalex.org/W2157717805","https://openalex.org/W1972864082","https://openalex.org/W2556946213","https://openalex.org/W1862870226","https://openalex.org/W2123437999","https://openalex.org/W2282452816","https://openalex.org/W2022970282"],"abstract_inverted_index":{"Obatoclax":[0,18,174],"mesylate":[1,175],"is":[2,204],"a":[3,35,45,54,91,119],"small":[4],"molecule":[5],"pan-Bcl-2":[6],"antagonist":[7],"with":[8,23,68,95,118,187,200,211],"in":[9,103,113,149,183,192,198],"vitro":[10],"activity":[11,178,182],"against":[12],"chronic":[13],"lymphocytic":[14],"leukemia":[15],"(CLL)":[16],"cells.":[17],"was":[19,76,147,158],"administered":[20],"to":[21,31,41,160],"patients":[22,52,89,117,186,196],"advanced":[24,188],"CLL":[25],"at":[26],"doses":[27],"ranging":[28],"from":[29,39],"3.5":[30],"14":[32],"mg/m(2)":[33,43,78],"as":[34,44,164],"1-hour":[36],"infusion":[37,47],"and":[38,66,105,130,145,154,179,197],"20":[40],"40":[42],"3-hour":[46],"every":[48,82],"3":[49,80,83],"weeks.":[50,84],"Twenty-six":[51],"received":[53],"total":[55],"of":[56,87,115,122,137,143,156,170],"74":[57],"cycles.":[58],"Dose-limiting":[59],"reactions":[60],"were":[61,111,139],"neurologic":[62],"(somnolence,":[63],"euphoria,":[64],"ataxia)":[65],"associated":[67],"the":[69,125,133,167],"infusion.":[70],"The":[71],"maximum":[72,126],"tolerated":[73],"dose":[74,140],"(MTD)":[75],"28":[77],"over":[79],"hours":[81],"One":[85],"(4%)":[86],"26":[88,116],"achieved":[90],"partial":[92],"response.":[93],"Patients":[94],"anemia":[96],"(3/11)":[97],"or":[98],"thrombocytopenia":[99],"(4/14)":[100],"experienced":[101],"improvements":[102],"hemoglobin":[104],"platelet":[106],"counts.":[107],"Circulating":[108],"lymphocyte":[109],"counts":[110],"reduced":[112],"18":[114],"median":[120],"reduction":[121],"24%.":[123],"Overall,":[124],"plasma":[127,168],"concentration":[128,169],"(C(max))":[129],"area":[131],"under":[132,213],"curve":[134],"(AUC)":[135],"values":[136],"obatoclax":[138,162],"proportional.":[141],"Activation":[142],"Bax":[144],"Bak":[146],"demonstrated":[148],"peripheral":[150],"blood":[151],"mononuclear":[152],"cells,":[153],"induction":[155],"apoptosis":[157],"related":[159],"overall":[161],"exposure,":[163],"monitored":[165],"by":[166],"oligonucleosomal":[171],"DNA/histone":[172],"complexes.":[173],"has":[176,208],"biologic":[177],"modest":[180],"single-agent":[181],"heavily":[184,194],"pretreated":[185,195],"CLL.":[189],"Further":[190],"evaluation":[191],"less":[193],"combination":[199],"other":[201],"therapeutic":[202],"agents":[203],"warranted.":[205],"This":[206],"trial":[207],"been":[209],"registered":[210],"http://clinicaltrials.gov":[212],"identifier":[214],"NCT00600964.":[215]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":23},{"year":2013,"cited_by_count":32},{"year":2012,"cited_by_count":28}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}